Home

kompas naživu mapa os overall survival trm V milosrdenství elektroda Vrásky

Unrelated umbilical cord blood can improve the prognosis of haploidentical  hematopoietic stem cell transplantation | Stem Cell Research & Therapy |  Full Text
Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation | Stem Cell Research & Therapy | Full Text

Intestinal microbiota score could predict survival following allogeneic  hematopoietic stem cell transplantation | SpringerLink
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink

Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic  Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era -  Clinical Lymphoma, Myeloma and Leukemia
Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia

IJMS | Free Full-Text | An Eleven-microRNA Signature Related to  Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML

Single-cell profiling defines the prognostic benefit of CD39high tissue  resident memory CD8+ T cells in luminal-like breast cancer | Communications  Biology
Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer | Communications Biology

Three-year probability of overall survival (OS), disease-free survival... |  Download Scientific Diagram
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram

Validity of the Minnesota aGvHD risk score in predicting survival and  response to therapy
Validity of the Minnesota aGvHD risk score in predicting survival and response to therapy

Overall survival (OS) of all patients (n = 3,011) according to age... |  Download Scientific Diagram
Overall survival (OS) of all patients (n = 3,011) according to age... | Download Scientific Diagram

Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101)  Post-Transplant Results in Decreased Transplant-Related Mortality and  Improved Survival in Acute Leukemia Patients Undergoing T-Depleted  Haploidentical Stem Cell Transplantation ...
Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ...

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients  autografted in first complete remission | Bone Marrow Transplantation
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation

Outcomes of adults with acute myelogenous leukemia in remission given 550  cGy of single-exposure total body irradiation, cyclophosphamide, and  unrelated donor bone marrow transplants - Biology of Blood and Marrow  Transplantation
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a  retrospective study in 285 patients from the Société F
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société F

Overall survival (OS) and relative survival by treatment intensity and... |  Download Scientific Diagram
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram

Experience of the Spanish Group for Hematopoietic Transplantation  (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in  Philadelphia acute lymphoblastic leukemia - ScienceDirect
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia - ScienceDirect

Musa Baris Aykan arşivleri - Medicine Science
Musa Baris Aykan arşivleri - Medicine Science

High proportions of CD3+ T cells in grafts delayed lymphocyte recovery and  reduced overall survival in haploidentical peripheral blood stem cell  transplantation
High proportions of CD3+ T cells in grafts delayed lymphocyte recovery and reduced overall survival in haploidentical peripheral blood stem cell transplantation

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M  advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor:  AURA3 overall survival analysis - Annals of Oncology
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology

CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA.... EHA  Library. Alderuccio J. Jun 12 2020; 295059
CHARACTERISTICS AND OUTCOMES OF HIV-RELATED BURKITT LYMPHOMA.... EHA Library. Alderuccio J. Jun 12 2020; 295059

Tissue-resident memory T cells in gastrointestinal cancer immunology and  immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer

Factors predicting long-term survival after T-cell depleted reduced  intensity allogeneic stem cell transplantation for acute myeloid leukemia |  Haematologica
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia | Haematologica

Overall survival and treatment-related mortality (TRM) by ABO... | Download  Scientific Diagram
Overall survival and treatment-related mortality (TRM) by ABO... | Download Scientific Diagram

Long-term event-free and overall survival after risk-adapted melphalan and  SCT for systemic light chain amyloidosis | Leukemia
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia